Treace Medical Concepts, Inc.
TMCI
$6.74
-$0.255-3.65%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.44% | 10.62% | 5.96% | 21.12% | 25.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.44% | 10.62% | 5.96% | 21.12% | 25.00% |
| Cost of Revenue | 15.36% | 11.95% | 14.41% | 25.97% | 27.14% |
| Gross Profit | 9.33% | 10.29% | 4.07% | 19.98% | 24.53% |
| SG&A Expenses | -5.44% | 0.16% | 18.48% | 22.84% | 31.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.20% | 2.81% | 19.69% | 25.11% | 29.53% |
| Operating Income | 97.77% | 15.06% | -63.82% | -37.30% | -93.94% |
| Income Before Tax | 92.02% | 12.33% | -72.81% | -38.81% | -42.36% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 92.02% | 12.33% | -72.81% | -38.81% | -42.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 92.02% | 12.33% | -72.81% | -38.81% | -42.36% |
| EBIT | 97.77% | 15.06% | -63.82% | -37.30% | -93.94% |
| EBITDA | 119.70% | 20.16% | -61.13% | -32.32% | -113.68% |
| EPS Basic | 92.14% | 13.28% | -70.89% | -31.91% | -28.21% |
| Normalized Basic EPS | 92.92% | 13.27% | -70.94% | -31.56% | -39.17% |
| EPS Diluted | 89.59% | 13.28% | -70.89% | -31.91% | -28.21% |
| Normalized Diluted EPS | 92.92% | 13.27% | -70.94% | -31.56% | -39.17% |
| Average Basic Shares Outstanding | 1.04% | 1.08% | 1.14% | 5.23% | 11.05% |
| Average Diluted Shares Outstanding | 1.04% | 1.08% | 1.14% | 5.23% | 11.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
